AIM Vaccine Co., Ltd. (HKG:6660)

AIM Vaccine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	342.58	494.27	583.14	635.18	646.74
Short-Term Investments	13.04	100.61	153.27	183.74	-
Trading Asset Securities	-	-	-	-	100
Cash & Short-Term Investments	355.62	594.87	736.42	818.91	746.74
Cash Growth	-40.22%	-19.22%	-10.07%	9.66%	-32.29%
Accounts Receivable	1,198	1,124	1,005	1,053	1,064
Other Receivables	11.64	44.5	57.33	5.95	15.82
Receivables	1,209	1,168	1,062	1,059	1,079
Inventory	347.41	462.61	509.86	504.74	367.4
Restricted Cash	28.94	47.59	42.24	11.17	22.32
Other Current Assets	101.72	114.07	132.02	155.34	142.75
Total Current Assets	2,043	2,387	2,483	2,549	2,359
Property, Plant & Equipment	3,108	3,479	3,522	3,488	2,871
Goodwill	271.45	271.45	271.45	482.9	482.9
Other Intangible Assets	236.94	268.81	288.63	305.94	311.73
Long-Term Deferred Tax Assets	128.61	109.97	95.33	-	-
Long-Term Deferred Charges	680.32	720.55	516.78	1,933	1,881
Other Long-Term Assets	76.67	76.72	85.34	117.6	167.48
Total Assets	6,544	7,314	7,262	8,876	8,072

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	79.98	50.89	60.36	73.58	51.76
Accrued Expenses	1,066	1,003	680.92	564.33	505.92
Short-Term Debt	1,116	1,122	1,151	966.61	397.39
Current Portion of Long-Term Debt	273.19	271.32	54.27	44.08	9.98
Current Portion of Leases	10.76	13.96	20.54	19.34	16.9
Current Income Taxes Payable	3.64	3.47	2.89	7.87	40.89
Current Unearned Revenue	23.56	41.31	63.04	62.02	45.65
Other Current Liabilities	520.41	583.63	568.45	511.96	501.56
Total Current Liabilities	3,093	3,090	2,602	2,250	1,570
Long-Term Debt	354.8	424.99	556.94	339.44	184.33
Long-Term Leases	2.1	8.54	12.43	29.19	41.83
Long-Term Unearned Revenue	149.32	154.42	159.99	127.44	85.03
Long-Term Deferred Tax Liabilities	8.81	25	41.16	269.01	491.83
Total Liabilities	3,608	3,703	3,372	3,015	2,373

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,227	1,211	1,211	1,211	1,200
Retained Earnings	-2,586	-1,911	-1,634	-332.68	-13.08
Comprehensive Income & Other	4,119	4,065	4,065	4,082	3,706
Total Common Equity	2,759	3,366	3,643	4,960	4,893
Minority Interest	177.32	245.59	246.82	900.67	806.7
Shareholders' Equity	2,937	3,611	3,890	5,861	5,699
Total Liabilities & Equity	6,544	7,314	7,262	8,876	8,072

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,756	1,841	1,796	1,399	650.43
Net Cash (Debt)	-1,401	-1,246	-1,059	-579.76	96.31
Net Cash Growth	-	-	-	-	-88.90%
Net Cash Per Share	-1.14	-1.03	-0.87	-0.48	0.08
Filing Date Shares Outstanding	1,227	1,211	1,211	1,211	1,200
Total Common Shares Outstanding	1,227	1,211	1,211	1,211	1,200
Working Capital	-1,050	-702.87	-118.96	298.91	788.64
Book Value Per Share	2.25	2.78	3.01	4.10	4.08
Tangible Book Value	2,251	2,825	3,083	4,171	4,098
Tangible Book Value Per Share	1.84	2.33	2.55	3.44	3.41
Buildings	1,022	1,035	1,024	806.39	682.19
Machinery	637.28	637.8	654.19	613.79	532.28
Construction In Progress	2,119	2,356	2,259	2,378	1,884
Leasehold Improvements	86.45	85.94	83.47	107.78	70.71

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error